SHENYANG, China, July 2 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced that it has filed with the SEC an annual report on Form 20-F for the year ended December 31, 2006. Copies of the report are available for download under the Investors page on the Company’s website at http://bbs.3sbio.com/en/News/ShowInfo_n16.aspx?ID=30 .
About 3SBio Inc.
3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China. For more information, please visit 3SBio on the web at http://www.3sbio.com .
For more information, please contact
Investor Contact:
Clara Mak, CFO
3SBio Inc.
Tel: +86-24-2581-1820
Email: ir@3sbio.com
Investor Relations (HK):
Ruby Yim
Taylor Rafferty
Tel: +852-3196-3712
Email: 3sbio@taylor-rafferty.com
Investor Relations (US):
Mahmoud Siddig
Taylor Rafferty
Tel: +1-212-889-4350
Email: 3sbio@taylor-rafferty.com
Media Contact:
John Dooley
Taylor Rafferty
Tel: +1-212-889-4350
Email: 3sbio@taylor-rafferty.com
